Search

WALL STREET PAYDAY: 4 banks made a killing from Monday's $20 billion in biotech deals

WALL STREET PAYDAY: 4 BANKS MADE A KILLING FROM MONDAY'S $20 BILLION IN BIOTECH DEALS

Biotech mergers and acquisitions are off to a hot start in 2018. On Monday, French drugmaker Sanofi spent $11.6 billion to buy US hemophilia...

Two drug companies are exploding after a pair of biotech mega-deals

TWO DRUG COMPANIES ARE EXPLODING AFTER A PAIR OF BIOTECH MEGA-DEALS

Markets Insider French drugmaker Sanofi is acquiring biotech company Bioverativ in a $11.6 billion deal. Celgene is acquiring Juno...

 
 
 
Sanofi is buying Bioverativ for $11.6 billion

SANOFI IS BUYING BIOVERATIV FOR $11.6 BILLION

Benoit Tessier/Reuters French drugmaker Sanofi is acquiring biotech company Bioverativ in a $11.6 billion deal. It's the biggest deal...